|
|
|
|
|
AravaNavigation: Home > Class Action Law> Arava
|
|
Five patients who used Aventis Pharma Ltd.'s Arava rheumatoid arthritis drug have died of pneumonia since the drug was launched in Japan. Eleven other users of the drug, generically known as leflunomide, have developed interstitial pneumonia. Arava was first launched in the United States in 1998 and has since become available in more than 70 countries. Worldwide, 10 people who have taken the drug have died due to interstitial pneumonia. A significant number of patients have also suffered liver damage. If you have experienced severe side effects due to this medication, seek an attorney, or find a firm devoted to class actions against Aventis Pharma. |
|
|
Sponsored Ads |
|
|
Sponsored Links |
|
|
|